Amneal launches Mesalamine; receives U.S. FDA Lenalidomide approval
Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment ...
Yamal to Messi? Player comps for Europe's elite U21 players
Comparing players is a risky business, but that doesn't mean it isn't fun! Is Yamal really the "new Messi'? Ryan O'Hanlon ...